Digene

Digene Corporation was a molecular diagnostics company with company headquarters in Gaithersburg, Maryland, U.S. Floyd Taub, M.D, founded the company in 1984 and it was incorporated in 1985.[1] In 1988, the first diagnostic test for human papillomavirus gained FDA approval; the test was ViraPap, developed by Life Technologies, which had been formed by the merger of GIBCO and Bethesda Research Laboratories in 1983. Clinical uptake was slow, and Life sold the test and associated intellectual property to Digene in 1990. It became Digene's most important product line.[2]

Digene
Founded1984 (1984)
Gaithersburg, Maryland, U.S.
FounderFloyd Taub
Defunct2007 (2007) (brought by Qiagen)
ProductsDiagnostics

In 2007, Qiagen bought the company for US$1.6 billion.[3]

References
  1. "Division of Corporations - Online Services". Archived from the original on 2011-07-21. Retrieved 2011-07-14.
  2. Hogarth, Stuart; Hopkins, Michael; Rotolo, Daniele (2015). "Chapter 5: Technological Accretion in Diagnostics: HPV Testing and Cytology in Cervical Cancer Screening". Medical Innovation: Science, technology and practice. Routledge. ISBN 9781138860346.
  3. "Netherlands' Qiagen buying Digene for $1.6 billion". Reuters. 2007-06-03. Retrieved 2020-05-01.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.